Effect of Vitamin D Supplementation on Skeletal Muscle Volume and Strength in Patients with Decompensated Liver Cirrhosis Undergoing Branched Chain Amino Acids Supplementation: A P...

por Okubo, Tomomi, Atsukawa, Masanori, Tsubota, Akihito, Ono, Hiroki, Kawano, Tadamichi, Yoshida, Yuji, Arai, Taeang, Hayama, Korenobu, Itokawa, Norio, Kondo, Chisa, Kaneko, Keiko, Iwakiri, Katsuhiko
Publicado 2021

A novel formula used for predicting hepatocellular carcinoma after the achievement of sustained virologic response by direct-acting antivirals in patients with chronic hepatitis C

por Yoshida, Yuji, Atsukawa, Masanori, Kondo, Chisa, Kitamura, Michika, Shioda-Koyano, Kaori, Kawano, Tadamichi, Ono, Hiroki, Hayama, Korenobu, Okubo, Tomomi, Arai, Taeang, Itokawa, Norio, Iwakiri, Katsuhiko
Publicado 2023

Anti-CD137 monoclonal antibody enhances trastuzumab-induced, natural killer cell-mediated cytotoxicity against pancreatic cancer cell lines with low human epidermal growth factor-l...

por Masu, Takushi, Atsukawa, Masanori, Nakatsuka, Katsuhisa, Shimizu, Masumi, Miura, Daishu, Arai, Taeang, Harimoto, Hirotomo, Kondo, Chisa, Kaneko, Keiko, Futagami, Seiji, Kawamoto, Chiaki, Takahashi, Hidemi, Iwakiri, Katsuhiko
Publicado 2018

How do the 2022 European Society of Cardiology/European Respiratory Society guidelines modify the diagnosis of portopulmonary hypertension in patients with cirrhosis complicated by...

por Atsukawa, Masanori, Tsubota, Akihito, Tamura, Yuichi, Koyano‐Shioda, Kaori, Kawano, Tadamichi, Okubo, Tomomi, Hayama, Korenobu, Arai, Taeang, Itokawa, Norio, Taniguchi, Yu, Tamura, Yudai, Kondo, Chisa, Iwakiri, Katsuhiko
Publicado 2023

Efficacy and safety of oral semaglutide in patients with non‐alcoholic fatty liver disease complicated by type 2 diabetes mellitus: A pilot study

por Arai, Taeang, Atsukawa, Masanori, Tsubota, Akihito, Ono, Hirotaka, Kawano, Tadamichi, Yoshida, Yuji, Okubo, Tomomi, Hayama, Korenobu, Nakagawa‐Iwashita, Ai, Itokawa, Norio, Kondo, Chisa, Nagao, Mototsugu, Iwakiri, Katsuhiko
Publicado 2022

Type III procollagen peptide level can indicate liver dysfunction associated with volume overload in acute heart failure

por Shirakabe, Akihiro, Okazaki, Hirotake, Matsushita, Masato, Shibata, Yusaku, Shigihara, Shota, Nishigoori, Suguru, Sawatani, Tomofumi, Sasamoto, Nozomi, Kiuchi, Kazutaka, Atsukawa, Masanori, Itokawa, Norio, Arai, Taeang, Kobayashi, Nobuaki, Asai, Kuniya
Publicado 2022

Factors Associated with Hepatitis B Surface Antigen Kinetics and Responses in Pegylated Interferon Alpha-2a Monotherapy for Patients with Chronic Hepatitis B

por Itokawa, Norio, Atsukawa, Masanori, Tsubota, Akihito, Shimada, Noritomo, Toyoda, Hidenori, Takaguchi, Koichi, Hiraoka, Atsushi, Senoh, Tomonori, Koeda, Mai, Yoshida, Yuji, Okubo, Tomomi, Arai, Taeang, Hayama, Korenobu, Nakagawa-Iwashita, Ai, Kondo, Chisa, Iwakiri, Katsuhiko
Publicado 2021

Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease

por Park, Huiyul, Yoon, Eileen L., Ito, Takanori, Jo, Ae Jung, Kim, Mimi, Lee, Jonghyun, Kim, Hye-Lin, Arai, Taeang, Atsukawa, Masanori, Kawanaka, Miwa, Toyoda, Hidenori, Ishigami, Masatoshi, Yu, Ming-Lung, Jun, Dae Won, Nguyen, Mindie H.
Publicado 2023

The Risk of Cirrhosis and Its Complications Based on PNPLA3 rs738409 G Allele Frequency

por Shao, Xue, Uojima, Haruki, Arai, Taeang, Ogawa, Yuji, Setsu, Toru, Atsukawa, Masanori, Furuichi, Yoshihiro, Arase, Yoshitaka, Horio, Kazue, Hidaka, Hisashi, Nakazawa, Takahide, Kako, Makoto, Kagawa, Tatehiro, Iwakiri, Katsuhiko, Nakajima, Atsushi, Terai, Shuji, Tanaka, Yasuhito, Koizumi, Wasaburo
Publicado 2022

Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease

por Arai, Taeang, Atsukawa, Masanori, Tsubota, Akihito, Kawano, Tadamichi, Koeda, Mai, Yoshida, Yuji, Tanabe, Tomohide, Okubo, Tomomi, Hayama, Korenobu, Iwashita, Ai, Itokawa, Norio, Kondo, Chisa, Kaneko, Keiko, Kawamoto, Chiaki, Hatori, Tsutomu, Emoto, Naoya, Iio, Etsuko, Tanaka, Yasuhito, Iwakiri, Katsuhiko
Publicado 2019

Shorter pruritus period and milder disease stage are associated with response to nalfurafine hydrochloride in patients with chronic liver disease

por Kawano, Tadamichi, Atsukawa, Masanori, Tsubota, Akihito, Shimada, Noritomo, Toyoda, Hidenori, Takaguchi, Koichi, Tani, Joji, Morishita, Asahiro, Hiraoka, Atsushi, Mikami, Shigeru, Ishikawa, Toru, Okubo, Hironao, Watanabe, Tsunamasa, Okubo, Tomomi, Arai, Taeang, Hayama, Korenobu, Itokawa, Norio, Kondo, Chisa, Iwakiri, Katsuhiko
Publicado 2022

Influencing factors on serum 25-hydroxyvitamin D(3) levels in Japanese chronic hepatitis C patients

por Atsukawa, Masanori, Tsubota, Akihito, Shimada, Noritomo, Yoshizawa, Kai, Abe, Hiroshi, Asano, Toru, Ohkubo, Yusuke, Araki, Masahiro, Ikegami, Tadashi, Kondo, Chisa, Itokawa, Norio, Nakagawa, Ai, Arai, Taeang, Matsushita, Yoko, Nakatsuka, Katsuhisa, Furihata, Tomomi, Chuganji, Yoshimichi, Matsuzaki, Yasushi, Aizawa, Yoshio, Iwakiri, Katsuhiko
Publicado 2015

Effect of sodium-glucose cotransporter 2 inhibitor in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a propensity score-matched analysis of real-worl...

por Arai, Taeang, Atsukawa, Masanori, Tsubota, Akihito, Mikami, Shigeru, Ono, Hiroki, Kawano, Tadamichi, Yoshida, Yuji, Tanabe, Tomohide, Okubo, Tomomi, Hayama, Korenobu, Nakagawa-Iwashita, Ai, Itokawa, Norio, Kondo, Chisa, Kaneko, Keiko, Emoto, Naoya, Nagao, Mototsugu, Inagaki, Kyoko, Fukuda, Izumi, Sugihara, Hitoshi, Iwakiri, Katsuhiko
Publicado 2021

Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease

por Kumagai, Erina, Mano, Yohei, Yoshio, Sachiyo, Shoji, Hirotaka, Sugiyama, Masaya, Korenaga, Masaaki, Ishida, Tsuyoshi, Arai, Taeang, Itokawa, Norio, Atsukawa, Masanori, Hyogo, Hideyuki, Chayama, Kazuaki, Ohashi, Tomohiko, Ito, Kiyoaki, Yoneda, Masashi, Kawaguchi, Takumi, Torimura, Takuji, Nozaki, Yuichi, Watanabe, Sumio, Mizokami, Masashi, Kanto, Tatsuya
Publicado 2016

Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease

por Arai, Taeang, Atsukawa, Masanori, Tsubota, Akihito, Kato, Keizo, Abe, Hiroshi, Ono, Hirotaka, Kawano, Tadamichi, Yoshida, Yuji, Tanabe, Tomohide, Okubo, Tomomi, Hayama, Korenobu, Nakagawa-Iwashita, Ai, Itokawa, Norio, Kondo, Chisa, Kaneko, Keiko, Emoto, Naoya, Nagao, Mototsugu, Inagaki, Kyoko, Fukuda, Izumi, Sugihara, Hitoshi, Iwakiri, Katsuhiko
Publicado 2021

Antifibrotic effect and long‐term outcome of SGLT2 inhibitors in patients with NAFLD complicated by diabetes mellitus

por Arai, Taeang, Atsukawa, Masanori, Tsubota, Akihito, Mikami, Shigeru, Haruki, Uojima, Yoshikata, Keiichiro, Ono, Hiroki, Kawano, Tadamichi, Yoshida, Yuji, Tanabe, Tomohide, Okubo, Tomomi, Hayama, Korenobu, Nakagawa‐Iwashita, Ai, Itokawa, Norio, Kondo, Chisa, Kaneko, Keiko, Nagao, Mototsugu, Inagaki, Kyoko, Fukuda, Izumi, Sugihara, Hitoshi, Iwakiri, Katsuhiko
Publicado 2022

Increased Frequency of Dysfunctional Siglec-7(−)CD57(+)PD-1(+) Natural Killer Cells in Patients With Non-alcoholic Fatty Liver Disease

por Sakamoto, Yuzuru, Yoshio, Sachiyo, Doi, Hiroyoshi, Mori, Taizo, Matsuda, Michitaka, Kawai, Hironari, Shimagaki, Tomonari, Yoshikawa, Shiori, Aoki, Yoshihiko, Osawa, Yosuke, Yoshida, Yuji, Arai, Taeang, Itokawa, Norio, Atsukawa, Masanori, Ito, Takanori, Honda, Takashi, Mise, Yoshihiro, Ono, Yoshihiro, Takahashi, Yu, Saiura, Akio, Taketomi, Akinobu, Kanto, Tatsuya
Publicado 2021

Characteristics and Prognosis of De Novo Hepatocellular Carcinoma After Sustained Virologic Response

por Toyoda, Hidenori, Hiraoka, Atsushi, Uojima, Haruki, Nozaki, Akito, Shimada, Noritomo, Takaguchi, Koichi, Abe, Hiroshi, Atsukawa, Masanori, Matsuura, Kentaro, Ishikawa, Toru, Mikami, Shigeru, Watanabe, Tsunamasa, Itobayashi, Ei, Tsuji, Kunihiko, Arai, Taeang, Yasuda, Satoshi, Chuma, Makoto, Senoh, Tomonori, Tsutsui, Akemi, Okubo, Tomomi, Ehira, Takuya, Kumada, Takashi, Tanaka, Junko
Publicado 2021

Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver disease

por Shoji, Hirotaka, Yoshio, Sachiyo, Mano, Yohei, Kumagai, Erina, Sugiyama, Masaya, Korenaga, Masaaki, Arai, Taeang, Itokawa, Norio, Atsukawa, Masanori, Aikata, Hiroshi, Hyogo, Hideyuki, Chayama, Kazuaki, Ohashi, Tomohiko, Ito, Kiyoaki, Yoneda, Masashi, Nozaki, Yuichi, Kawaguchi, Takumi, Torimura, Takuji, Abe, Masanori, Hiasa, Yoichi, Fukai, Moto, Kamiyama, Toshiya, Taketomi, Akinobu, Mizokami, Masashi, Kanto, Tatsuya
Publicado 2016

Early Changes in Circulating FGF19 and Ang-2 Levels as Possible Predictive Biomarkers of Clinical Response to Lenvatinib Therapy in Hepatocellular Carcinoma

por Chuma, Makoto, Uojima, Haruki, Numata, Kazushi, Hidaka, Hisashi, Toyoda, Hidenori, Hiraoka, Atsushi, Tada, Toshifumi, Hirose, Shunji, Atsukawa, Masanori, Itokawa, Norio, Arai, Taeang, Kako, Makoto, Nakazawa, Takahide, Wada, Naohisa, Iwasaki, Shuitirou, Miura, Yuki, Hishiki, Satoshi, Nishigori, Shuhei, Morimoto, Manabu, Hattori, Nobuhiro, Ogushi, Katsuaki, Nozaki, Akito, Fukuda, Hiroyuki, Kagawa, Tatehiro, Michitaka, Kojiro, Kumada, Takashi, Maeda, Shin
Publicado 2020